From: A common gene expression signature in Huntington’s disease patient brain regions
Set | Accession | ctr/patient | Tissue | Array | Overlap | Reference |
---|---|---|---|---|---|---|
main HD | GSE3790 | 26/38 | cerebellum | GPL96 | 100% | [27] |
16/18 | BA4 region of frontal cortex | |||||
12/18 | BA9 region of frontal cortex | |||||
32/36 | caudate nucleus | |||||
AD | GSE26927 | 7/11 | entorhinal cortex | GPL6255 | 94.2% | [35] |
ALS | 9/10 | cervical spinal cord | ||||
HD-II | 10/9 | ventral head of the caudate nucleus | ||||
MS | 10/8 | superior frontal gyri | ||||
PD | 8/12 | substantia nigra | ||||
SCHIZ | 8/9 | temporal cortex left, BA22 region | ||||
DM1 | GSE7014 | 5/10 | skeletal muscle | GPL570 | 100% | [81] |
DM2 | 5/20 | skeletal muscle | ||||
DMD | GSE6011 | 14/22 | quadriceps muscle | GPL96 | 100% | [82] |
DCM | GSE3585 | 5/7 | heart | GPL96 | 100% | [83] |
RCC | GSE781 | 5/12 | kidney | GPL96 | 100% | [84] |
GG | E-MEXP-1690 | 6/6 | brain | GPL96 | 100% | [85] |
Set | Accession | WT/HD | Tissue | Array | Overlap | Reference |
Q80 | GSE10263 | 3/3 | striatum | GPL81 | 51.2% | [28] |
Q150 | GSE10263 | 4/4 | striatum | GPL1261 | 81.9% | |
Q92 | GSE7958 | 3/3 (3 mth) | striatum | GPL1261 | 81.9% | |
3/3 (18 mth) | ||||||
R6/2 | GSE10263 | 9/9 | striatum | GPL1261 | 81.9% | |
YAC128 | GSE19677 | 4/4 (12 mth) 3/6 (24 mth) | striatum | GPL1261 | 81.9% | [24] |